Metalidis C et al. |
Expression of CYP3A5 and P-glycoprotein in renal allografts with histological signs of calcineurin inhibitor nephrotoxicity. |
2011 |
Transplantation |
pmid:21544031
|
Dumont FJ et al. |
A tacrolimus-related immunosuppressant with reduced toxicity. |
1998 |
Transplantation |
pmid:9448138
|
Miyauchi T et al. |
Effect of donor-specific splenocytes via portal vein and FK506 in rat small bowel transplantation. |
1998 |
Transplantation |
pmid:9448139
|
Mieles L et al. |
Interaction between FK506 and clotrimazole in a liver transplant recipient. |
1991 |
Transplantation |
pmid:1721250
|
Roth D et al. |
A prospective study of hepatitis C virus infection in renal allograft recipients. |
1996 |
Transplantation |
pmid:8623154
|
Shin BH et al. |
Regulation of anti-HLA antibody-dependent natural killer cell activation by immunosuppressive agents. |
2014 |
Transplantation |
pmid:24342979
|
Yoon SH et al. |
CYP3A and ABCB1 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of tacrolimus and its metabolites (M-I and M-III). |
2013 |
Transplantation |
pmid:23364483
|
Calmus Y et al. |
Assessing renal function with daclizumab induction and delayed tacrolimus introduction in liver transplant recipients. |
2010 |
Transplantation |
pmid:20495510
|
Zoppo A et al. |
Trimetazidine counteracts tacrolimus nephrotoxicity in a hypertensive liver transplant patient. |
1999 |
Transplantation |
pmid:10551656
|
Egli A et al. |
Inhibition of polyomavirus BK-specific T-Cell responses by immunosuppressive drugs. |
2009 |
Transplantation |
pmid:19935369
|
Takahara S et al. |
The in vitro immunosuppressive effect of deoxymethylspergualin in man as compared with FK506 and cyclosporine. |
1992 |
Transplantation |
pmid:1373537
|
Metcalfe SM and Richards FM |
Cyclosporine, FK506, and rapamycin. Some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells. |
1990 |
Transplantation |
pmid:1691537
|
Jain A et al. |
Delayed introduction of tacrolimus postliver transplant with intravenous mycophenolate mofetil preserves renal function without incurring rejection. |
2014 |
Transplantation |
pmid:25285953
|
Timmermann W et al. |
Videomicroscopic imaging of graft mucosa for monitoring immunosuppressive therapy after small intestinal transplantation in rats. |
1999 |
Transplantation |
pmid:10401762
|
Fujimura Y and Owen RL |
Tacrolimus (FK506) and cyclosporine reduce the uptake and transport of particles into rabbit Peyer's patches. |
2002 |
Transplantation |
pmid:11965030
|
Castells L et al. |
Liver transplantation in HIV-HCV coinfected patients: a case-control study. |
2007 |
Transplantation |
pmid:17297413
|
Kaufman DB et al. |
Mycophenolate mofetil and tacrolimus as primary maintenance immunosuppression in simultaneous pancreas-kidney transplantation: initial experience in 50 consecutive cases. |
1999 |
Transplantation |
pmid:10071032
|
Khanna A et al. |
Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells. |
1999 |
Transplantation |
pmid:10071036
|
Bozorgzadeh A et al. |
Impact of hepatitis C viral infection in primary cadaveric liver allograft versus primary living-donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus. |
2004 |
Transplantation |
pmid:15087773
|
Mor E et al. |
Late-onset acute rejection in orthotopic liver transplantation--associated risk factors and outcome. |
1992 |
Transplantation |
pmid:1279849
|
Diem HV et al. |
Pediatric liver transplantation for biliary atresia: results of primary grafts in 328 recipients. |
2003 |
Transplantation |
pmid:12777858
|
Butani L et al. |
Amelioration of tacrolimus-induced nephrotoxicity in rats using juniper oil. |
2003 |
Transplantation |
pmid:12883183
|
Smets F et al. |
Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease. |
2002 |
Transplantation |
pmid:12042647
|
Couzi L et al. |
Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients. |
2008 |
Transplantation |
pmid:18946343
|
Horner BM et al. |
Recipient damage after musculocutaneous transplant rejection. |
2008 |
Transplantation |
pmid:18946349
|
Andoh TF et al. |
Enhancement of FK506 nephrotoxicity by sodium depletion in an experimental rat model. |
1994 |
Transplantation |
pmid:7509514
|
Imado T et al. |
Effect of FK506 on donor T-cell functions that are responsible for graft-versus-host disease and graft-versus-leukemia effect. |
2004 |
Transplantation |
pmid:14966413
|
Higgins RM et al. |
Acute rejection after renal transplantation is reduced by approximately 50% by prior therapeutic blood transfusions, even in tacrolimus-treated patients. |
2004 |
Transplantation |
pmid:14966430
|
Woodle ES et al. |
A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group. |
1996 |
Transplantation |
pmid:8830821
|
Herlenius G et al. |
Chronic kidney disease--a common and serious complication after intestinal transplantation. |
2008 |
Transplantation |
pmid:18622286
|
Mañez R et al. |
Anomalous pattern of IgG antibody response to primary cytomegalovirus infection after solid organ retransplantation. |
1995 |
Transplantation |
pmid:7537400
|
Pacifico L et al. |
Tacrolimus and food allergy. |
2003 |
Transplantation |
pmid:14688538
|
Sulanc E et al. |
New-onset diabetes after kidney transplantation: an application of 2003 International Guidelines. |
2005 |
Transplantation |
pmid:16249743
|
Mourad M et al. |
Sirolimus and tacrolimus trough concentrations and dose requirements after kidney transplantation in relation to CYP3A5 and MDR1 polymorphisms and steroids. |
2005 |
Transplantation |
pmid:16249748
|
Vyas S et al. |
Outcome of twin pregnancy in a renal transplant recipient treated with tacrolimus. |
1999 |
Transplantation |
pmid:10030303
|
Ji E et al. |
Combinational effect of intestinal and hepatic CYP3A5 genotypes on tacrolimus pharmacokinetics in recipients of living donor liver transplantation. |
2012 |
Transplantation |
pmid:22992768
|
Schena FP et al. |
Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. |
2009 |
Transplantation |
pmid:19155978
|
Muthukkumar S et al. |
Rapamycin, a potent immunosuppressive drug, causes programmed cell death in B lymphoma cells. |
1995 |
Transplantation |
pmid:7544036
|
Muraki T et al. |
Antithrombotic effect of FK506 versus prothrombotic effect of cyclosporine in vivo. |
1995 |
Transplantation |
pmid:7544038
|
Boots JM et al. |
Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study. |
2002 |
Transplantation |
pmid:12499885
|
Hebert MF et al. |
Interpreting tacrolimus concentrations during pregnancy and postpartum. |
2013 |
Transplantation |
pmid:23274970
|
Molmenti EP et al. |
Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection. |
2001 |
Transplantation |
pmid:11213072
|
Min SI et al. |
CYP3A5 *1 allele: impacts on early acute rejection and graft function in tacrolimus-based renal transplant recipients. |
2010 |
Transplantation |
pmid:21076384
|
Thai NL et al. |
Pancreas transplantation under alemtuzumab (Campath-1H) and tacrolimus: Correlation between low T-cell responses and infection. |
2006 |
Transplantation |
pmid:17198253
|
Jain AB et al. |
Capillary blood versus arterial or venous blood for tacrolimus monitoring in liver transplantation. |
1995 |
Transplantation |
pmid:7545836
|
Vincenti F et al. |
One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group. |
1996 |
Transplantation |
pmid:8669100
|
Letavernier E et al. |
Proteinuria following a switch from calcineurin inhibitors to sirolimus. |
2005 |
Transplantation |
pmid:16314786
|
Wai LE et al. |
Rapamycin, but not cyclosporine or FK506, alters natural killer cell function. |
2008 |
Transplantation |
pmid:18192925
|
Bolley R et al. |
Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St John's wort. |
2002 |
Transplantation |
pmid:11923712
|
Burger CI et al. |
Case report: drug interaction between tacrolimus and amiodarone with QT prolongation. |
2010 |
Transplantation |
pmid:20440199
|